Kymriah Injection, Suspension
Product Images NDC 0078-0958

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Kymriah (NDC 0078-0958). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Note: The Patient Identifier Number May Be Preceded By The Letters Din Or Aph Id. (Kymriah 01)

FDA Label Image

Principal Display Paneltisagenlecleucelkymriahtmndc 0078-0846-19human T Cellsrx Only Suspension For Iv Infusioncultured, Genetically Modifiedfor Autologous Use Onlydispense With Medication Guidenovartis (Kymriah 02)

This is a medication called Tisagenlecleucel Himentes, available in suspended form for intravenous infusion use. It is genetically modified and exclusively meant for autologous use only. One bag can contain 10-50mL of the total volume. It is cryopreserved and needs to be stored at very low temperatures. This medication is not evaluated for infectious substances and has instructions not to use a leukocyte-depleting filter or irradiate it. The manufacturer is Novartis Pharmaceuticals Corporation, and for details, their website KYMRIAH.com should be visited. The package needs to be dispensed with the medication guide. The provided number can be called for further information or in case of any query. There is no information on this text about the actual use of this medication.*

FDA Label Image

Kymriah 03

This is a medication called OKYMRIAH, with the generic name Tisagenlecleucel. It is a suspension for intravenous infusion and requires a medication guide for dispensing. The dosage is to be determined based on the prescription provided. It is packaged in bags with a volume of 10mL-50mL. It is cryopreserved using several substances, including T cells. The medication is to be stored at <-120°C and is manufactured by Novartis Pharmaceuticals Corporation. The product is not evaluated for infectious substances, and caution is advised while administering the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.